DR. NEVINS W TODD, M.D.
Osteopathic Medicine at Greene St, Baltimore, MD
License number
Maryland F30784
Category
Osteopathic Medicine
Type
Critical Care Medicine
License number
Maryland F30784
Category
Osteopathic Medicine
Type
Pulmonary Disease
Address
Address
22 S Greene St, Baltimore, MD 21201
Phone
(410) 705-5246
(410) 705-7915 (Fax)
(410) 705-7915 (Fax)
Personal information
See more information about NEVINS W TODD at radaris.comName
Address
Phone
201 Pine Bluff Rd, Salisbury, MD 21801
216 Sandy Bottom Ct, Salisbury, MD 21804
Ocean City, MD
201 Pine Bluff Rd, Salisbury, MD 21801
8311 Saddle Ridge Ter, Ellicott City, MD 21043
Professional information
Dr. Nevins W Todd, Baltimore MD - MD (Doctor of Medicine)
Specialties:
Critical Care Medicine, Pulmonology
Address:
Univ Maryland Medical Group
419 W Redwood St SUITE 600, Baltimore 21201
(410) 328-5738 (Phone)
419 W Redwood St SUITE 600, Baltimore 21201
(410) 328-5738 (Phone)
Certifications:
Critical Care Medicine, 1993, Internal Medicine, 1989, Pulmonary Disease, 1992
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Univ Maryland Medical Group
419 W Redwood St SUITE 600, Baltimore 21201
University of Maryland Medical Center
22 South Greene St, Baltimore 21201
419 W Redwood St SUITE 600, Baltimore 21201
University of Maryland Medical Center
22 South Greene St, Baltimore 21201
Education:
Medical School
University of Maryland At Baltimore / Professional Schools
Graduated: 1986
Mercy Medical Center
Duke University Hospital
University of Maryland At Baltimore / Professional Schools
Graduated: 1986
Mercy Medical Center
Duke University Hospital
Nevins Woodcock Todd, Baltimore MD
Specialties:
Internal Medicine, Critical Care Medicine, Pulmonary Disease, Critical Care Medicine
Work:
University of Maryland
22 S Greene St, Baltimore, MD 21263 University of Maryland
419 W Redwood St, Baltimore, MD 21201
22 S Greene St, Baltimore, MD 21263 University of Maryland
419 W Redwood St, Baltimore, MD 21201
Education:
University of Maryland(1986)
Antifibrotic Therapy
US Patent:
2009013, May 21, 2009
Filed:
Nov 18, 2008
Appl. No.:
12/273149
Inventors:
Sergei P. Atamas - Ellicot City MD, US
Irina G. Luzina - Ellicott City MD, US
Nevins W. Todd - Baltimore MD, US
Irina G. Luzina - Ellicott City MD, US
Nevins W. Todd - Baltimore MD, US
International Classification:
A61K 48/00, C12Q 1/02
US Classification:
514 44, 435 29
Abstract:
The present invention relates to methods of treating severe or rapidly progressing pulmonary fibrosis in a subject in need of a treatment thereof. The methods comprise increasing the activity of pulmonary and activation-regulated chemokine (CCL18) in the lungs of the subject, whereby increasing CCL18 activity modulates the activity of at least one antifibrotic factor in the lungs of the subject. The present invention also relates to methods of screening test procedures that may be capable of treating severe or rapidly progressing pulmonary fibrosis.